IAMERS SUPPORTS ITS MEMBERS IN MANY WAYS.
Networking, Education, Patient Safety and Advocacy. With declining provider revenues, stronger business practices and an industry in transition, you need to know information critical to your business. IAMERS is following what matters most to your business.
Our efforts are gaining recognition and momentum as the marketplace is recognizing the importance and cost effectiveness of the Independent Provider of services and devices. For many if these less expensive, but clinically relevant, options were not available then their patients would miss receiving the health care they need and deserve.
Take the time to learn about our efforts in the regulatory and legislative arenas.
7.26.12 – GAO report on the ACA implementation of “Meaningful Use” show few hospitals and professionals qualify
http://www.gao.gov/assets/600/593078.pdf In case you forgot what it means here's a working definition for Meaningful Use. From a publication of the Robert Woods Johnson Foundation: Glossary of Health Care Quality Terms, Meaningful use— Meaningful use [...]
Diana Upton, IAMERS President and Casper Uldriks, FDA expert and former Associate Director at the FDA, team up in a recent DOTmed News interview
In the interview they discuss the FDA UDI (unique device identifier) regulation and the 2.3% excise tax on capital equipment imposed under the ACA and the potential for each to [...]
Medical Device Excise Tax Begins In Five Months
IAMERS met with tax counsel from a senior member on the U.S. House Ways and Means Committee to discuss some need for clarification of the medical device excise tax (currently [...]